{"wiki_id": "http://www.wikidata.org/entity/Q55614235", "itemLabel": "Ian Gibbons", "itemDescription": "American biochemist", "wikipedia_url": "https://en.wikipedia.org/wiki/Ian_Gibbons_(biochemist)", "wikipedia_page": {"main": "Ian Gibbons (March 6, 1946 - May 23, 2013) was the chief scientist of Theranos. The British biochemist, who held a doctorate from the University of Cambridge, had worked for 30 years in diagnostic and therapeutic industry before joining Theranos in 2005. In 2013 Gibbons took an overdose the night before he was required to testify in a lawsuit about the health company's technology. He died of liver failure several days after his suicide attempt. In 2018 Theranos collapsed after it became known its small automated testing devices that it was developing to do blood tests never actually worked.", "link_mentions": [{"page": "Theranos", "response": ["* Ian Gibbons, Theranos's chief scientist who died by suicide in 2013"]}, {"page": "Ian Gibbons (diagnostician)", "response": ["#REDIRECT Ian Gibbons (biochemist)"]}, {"page": "Ian Gibbons", "response": ["Ian Gibbons may refer to:", "* Ian Gibbons (biochemist) (1946\u20132013), chief scientist of Theranos", "* Ian Gibbons (musician) (1952\u20132019), English keyboardist", "* Ian Gibbons (footballer) (born 1970), English football player"]}, {"page": "The Inventor: Out for Blood in Silicon Valley", "response": ["* Rochelle Gibbons, the widow of Ian Gibbons, Theranos's chief biochemist. Ian Gibbons did much of the work behind the patents filed by Holmes, told Holmes problems with the technology and was rebuffed, and committed suicide in 2013."]}, {"page": "Channing Robertson", "response": ["Robertson taught Theranos founder Elizabeth Holmes when she was a student at Stanford, and he went on to become the company's first board member. He convinced Ian Gibbons to work for Theranos in 2005. In 2017, Theranos named him the co-leader of their technology advisory board. Even as Theranos was coming under growing scrutiny, as of May 2018, Robertson still believed the company was successful in developing novel blood testing technology. According to lawyer Reed Kathrein, who sued Theranos on behalf of some of its former investors, the company only paid Robertson to lend itself credibility."]}]}}